A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexMale
Age18-90
SponsorAntelope Surgical Solutions, Inc
About this trial
A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS
Eligibility criteria
Qualifiers
suspected prostate cancer warranting standard of care multi-core prostate biopsy
Disqualifiers
Patients receiving same-day therapeutic Lutetium-177 or Actinium-225 PSMA receptor radiation isotope therapy treatment
Patients with pre-existing, impaired or abnormal hepatic function, renal function, cardiac function, and abnormal elevated temperature
Patients with a creatinine clearance cutoff (CrCl) of < 60 mL/min
Trial design
Treatments tested in this trial
- AS1986NS
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov